{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T14:06:01Z","timestamp":1692367561029},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s12094-010-0520-x","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T02:30:50Z","timestamp":1274149850000},"page":"381-383","source":"Crossref","is-referenced-by-count":4,"title":["Haemolytic uraemic syndrome associated with gemcitabine"],"prefix":"10.1007","volume":"12","author":[{"given":"Irene","family":"Moya-Horno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Querol Ni\u00f1erola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Bonfill Abella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Dalmau P\u00f3rtulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Gallardo-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugeni","family":"Saig\u00ed Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Pericay Pijaume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,19]]},"reference":[{"key":"520_CR1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF03187336","volume":"6","author":"M.F. Loreto","year":"2000","unstructured":"Loreto MF, De Martinis M, Corsi MP et al (2000) Coagulation and cancer: implications for diagnosis and management. Pathol Onol Res 6:301\u2013312","journal-title":"Pathol Onol Res"},{"key":"520_CR2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/ndt\/13.1.76","volume":"13","author":"M. Hollenbeck","year":"1998","unstructured":"Hollenbeck M, Kutkuhn B, Aul C et al (1998) Haemolytic-uraemic syndrome and thromboticthrombocytopaenic purpura in adults: clinical findings and prognostic factors for death and end-stage renal disease. Nephrol Dial Transplant 13:76\u201381","journal-title":"Nephrol Dial Transplant"},{"key":"520_CR3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000174075","volume":"19","author":"W. Proesmans","year":"1996","unstructured":"Proesmans W (1996) Typical and atypical haemolytic uremic syndrome. Kidney Blood Press Res 19:205\u2013208","journal-title":"Kidney Blood Press Res"},{"key":"520_CR4","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/archinte.1995.00430190069009","volume":"155","author":"A.M. Melnyk","year":"1995","unstructured":"Melnyk AM, Solez K, Kjellstrand CM (1995) Adult haemolytic-uraemic syndrome. A review of 37 cases. Arch Intern Med 155:2077\u20132084","journal-title":"Arch Intern Med"},{"key":"520_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/08860228709056324","volume":"10","author":"J.A. D\u2019Elia","year":"1987","unstructured":"D\u2019Elia JA, Aslani M, Schermer S et al (1987) Haemolytic-uraemic syndrome and acute renal failure in meetastatic adenocarcinoma treated with mitomycin: case report and literature review. Ren Fail 10:107\u2013113","journal-title":"Ren Fail"},{"key":"520_CR6","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/1097-0142(19861001)58:7<1428::AID-CNCR2820580709>3.0.CO;2-J","volume":"58","author":"R. Sheldon","year":"1986","unstructured":"Sheldon R, Slaughter D (1986) A syndrome of microangiopathic haemolytic anaemia, renal impairment, and pulmonary oedema in chemotherapy-treated patients with adenocarcinoma. Cancer 58:1428\u20131436","journal-title":"Cancer"},{"key":"520_CR7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0248-8663(01)00535-5","volume":"23","author":"M.S. Dilhuydy","year":"2002","unstructured":"Dilhuydy MS, Delclaux C, Pariente A et al (2002) Syndrome h\u00e9molytique et ur\u00e9mique compliquant un traitement au long cours par gemcitabine. Rev Med Interne 23:189\u2013192","journal-title":"Rev Med Interne"},{"key":"520_CR8","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1053\/ajkd.2002.35758","volume":"40","author":"R.B. Walter","year":"2002","unstructured":"Walter RB, Joerger M, Pestalozzi BC (2002) Gemcitabine associated haemolytic uraemic syndrome. Am J Kidney Dis 40: E16","journal-title":"Am J Kidney Dis"},{"key":"520_CR9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ajhp\/54.2.162","volume":"54","author":"Y.F. Hui","year":"1997","unstructured":"Hui YF, Reitz J (1997) Gemcitabine: a cytidine analogue active against solid tumors. Am J Health-System Pharm 54:162\u2013170","journal-title":"Am J Health-System Pharm"},{"key":"520_CR10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajh.2830330109","volume":"33","author":"J. Monteagudo","year":"1990","unstructured":"Monteagudo J, Pereira A, Roig S et al (1990) Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related haemolytic uraemia syndrome. Am J Hematol 33:46\u201349","journal-title":"Am J Hematol"},{"key":"520_CR11","first-page":"161","volume":"24","author":"A.J. Murgo","year":"1987","unstructured":"Murgo AJ (1987) Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol 24:161\u2013177","journal-title":"Semin Hematol"},{"key":"520_CR12","first-page":"369","volume":"6","author":"M. Wasif Saif","year":"2005","unstructured":"Wasif Saif M, Mc Gee PJ (2005) Haemolyticuraemic syndrome associated with gemcitabine: a case report and review of literature. J Pancreas 6: 369\u2013374","journal-title":"J Pancreas"},{"key":"520_CR13","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cncr.20290","volume":"100","author":"D.H. Benjam\u00edn","year":"2004","unstructured":"Benjam\u00edn DH, Jeff PS, Joel MH et al (2004) Gemcitabine-associated thrombotic microangiopathy. Cancer 100:2664\u20132670","journal-title":"Cancer"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-010-0520-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-010-0520-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-010-0520-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:50:49Z","timestamp":1559447449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-010-0520-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["520"],"URL":"https:\/\/doi.org\/10.1007\/s12094-010-0520-x","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}